Drugs / DC cell suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02862561 | Aug 2016 → Mar 2018 | cancer | Shanghai International Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC cell suspension | “DC cell suspension (1×10\*7 DC+physiological saline + 0.25% human bloodalbumin)1ml for each infusion, subcutaneous injection for each infusion” NCT02862561 ↗ |
| Route | Subcutaneous | “subcutaneous injection for each infusion” NCT02862561 ↗ |